The study, sponsored by Georgetown University, targets rehabilitation and prophylaxis of anomia in patients with Primary Progressive Aphasia (PPA) and Alzheimer's Disease. Given the increasing prevalence of dementia-related disorders, successful outcomes could position this intervention as a novel therapeutic approach in cognitive rehabilitation, potentially opening avenues for commercialization in the growing dementia care market. The focus on word-finding issues may also attract interest from pharmaceutical companies and investors looking to enhance cognitive function therapies, especially as the aging population expands. Competitive implications include the need to monitor similar interventions targeting cognitive decline, particularly those that leverage behavioral therapies or neuroplasticity.